LYON, FRANCE / ACCESSWIRE / December 17, 2024 / Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases (the "Company"), today presents an update of its cash ...
Bally's Corporation ("Bally's") today announced that it has completed the previously announced sale lease-back of certain real property interests underlying Bally's Kansas City and Bally's Shreveport ...